About the Genitourinary Cancers Session
Genitourinary oncology encompasses cancers of the urinary system and male reproductive organs and continues to benefit from rapid advances in imaging, surgery, systemic treatment, targeted therapies, and immunotherapy. This session provides a multidisciplinary platform for research and clinical developments across genitourinary malignancies.
Abstract Scope and Participation
Submissions may address prostate, kidney, bladder, urothelial, testicular, penile, and other genitourinary cancers. Research on diagnosis, biomarkers, surgery, radiotherapy, hormonal therapy, targeted treatment, immunotherapy, and advanced disease management is welcomed from clinicians, scientists, surgeons, and multidisciplinary teams.
Topics Covered in Genitourinary Cancers
Prostate Cancer
Kidney Cancer
Bladder Cancer
Testicular Cancer
Penile Cancer
GU Cancer Therapies
Related Scientific Sessions at CIOC 2027
Why Attend the Genitourinary Cancers Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Genitourinary Cancers work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Genitourinary Cancers research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Genitourinary Cancers track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Genitourinary Cancers Conference 2027 — FAQs
What is the Genitourinary Cancers track at CIOC 2027?
The Genitourinary Cancers track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Genitourinary Cancers. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Genitourinary Cancers sessions?
Cancer researchers and clinicians, educators and students with an interest in Genitourinary Cancers are all welcome — whether presenting or attending.
Can I present my research in the Genitourinary Cancers track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Genitourinary Cancers sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Genitourinary Cancers track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.